Immunome (IMNM) EBT Margin (2023 - 2025)

Immunome's (IMNM) quarterly EBT Margin came in at 1751.01% in Q2 2025, up 189650.0% YoY from N/an in Q2 2024, and down 14.11% on a QoQ basis from 1534.52% in Q1 2025.

Immunome (IMNM) EBT Margin (2023 - 2025) Analysis & Trends

Immunome (IMNM) has 3 years of EBT Margin data on file, last reported at 1751.01% in Q2 2025.

  • Quarterly EBT Margin rose 189650.0% year-over-year to 1751.01% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 12187.25% (down 916542.0% YoY) and the FY2025 annual result came in at 5831.74%, down 126897.0% from the prior year.
  • EBT Margin eased to 1751.01% in Q2 2025, from 1534.52% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 193.36% in Q1 2023 to a low of 12866.76% in Q1 2024.
  • A 3-year average of 3032.19% and a median of 2113.29% in 2025 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2024 — EBT Margin plunged 1267341 bps — and 2025, when it jumped 1133225 bps.
  • Tracing IMNM's EBT Margin over 3 years: stood at 2475.56% in 2023, then slipped by 23 bps to 3041.27% in 2024, then jumped by 42 bps to 1751.01% in 2025.
  • The last three EBT Margin figures came in at 1751.01% (Q2 2025), 1534.52% (Q1 2025), and 3041.27% (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Immunome 3.09 Bn 2.57 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,751.01%
Mar 31, 2025 -1,534.52%
Dec 31, 2024 -3,041.27%
Sep 30, 2024 -3,990.76%
Jun 30, 2024 -3,647.50%
Mar 31, 2024 -12,866.76%
Dec 31, 2023 -2,475.56%
Sep 30, 2023 -444.12%
Jun 30, 2023 -377.03%
Mar 31, 2023 -193.36%